Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $12.3 Million - $17.7 Million
1,650,000 Added 19.41%
10,150,000 $104 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $39.6 Million - $52.1 Million
5,500,000 Added 183.33%
8,500,000 $64 Million
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $33.4 Million - $45.5 Million
-4,000,000 Reduced 57.14%
3,000,000 $26.6 Million
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $3.98 Million - $4.74 Million
-500,000 Reduced 6.67%
7,000,000 $63.8 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $32.6 Million - $56.8 Million
4,750,000 Added 172.73%
7,500,000 $60.5 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $17.8 Million - $22.9 Million
-2,250,000 Reduced 45.0%
2,750,000 $22 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $4.19 Million - $5.09 Million
-500,000 Reduced 9.09%
5,000,000 $48.7 Million
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $10.3 Million - $12.8 Million
1,000,000 Added 22.22%
5,500,000 $63.5 Million
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $21.4 Million - $31.7 Million
2,500,000 Added 125.0%
4,500,000 $40.5 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $16.2 Million - $26.2 Million
2,000,000 New
2,000,000 $24.7 Million
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $13.4 Million - $26.9 Million
-2,000,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $13.1 Million - $21.4 Million
2,000,000 New
2,000,000 $19.6 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $40 Million - $62.4 Million
-6,500,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $24.4 Million - $47.2 Million
3,000,000 Added 85.71%
6,500,000 $60 Million
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $54.5 Million - $70 Million
3,500,000 New
3,500,000 $54.9 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Camber Capital Management LP Portfolio

Follow Camber Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.